C-Rad Valuation

Is CRAD B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CRAD B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CRAD B (SEK28.25) is trading below our estimate of fair value (SEK88.82)

Significantly Below Fair Value: CRAD B is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CRAD B?

Key metric: As CRAD B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CRAD B. This is calculated by dividing CRAD B's market cap by their current earnings.
What is CRAD B's PE Ratio?
PE Ratio	16.4x
Earnings	SEK 57.93m
Market Cap	SEK 948.59m

CRAD B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.7x
Enterprise Value/EBITDA	11.7x
PEG Ratio	0.5x

Price to Earnings Ratio vs Peers

How does CRAD B's PE Ratio compare to its peers?

The above table shows the PE ratio for CRAD B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	29.6x
PAX Paxman	49.1x	60.8%	SEK 1.3b
CARE Careium	16.3x	16.5%	SEK 705.5m
ADDV A ADDvise Group	17.1x	21.1%	SEK 727.8m
STIL Stille	35.9x	35.0%	SEK 1.8b
CRAD B C-Rad	16.4x	34.7%	SEK 948.6m

Price-To-Earnings vs Peers: CRAD B is good value based on its Price-To-Earnings Ratio (16.4x) compared to the peer average (29.6x).

Price to Earnings Ratio vs Industry

How does CRAD B's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: CRAD B is good value based on its Price-To-Earnings Ratio (16.4x) compared to the European Medical Equipment industry average (29.5x).

Price to Earnings Ratio vs Fair Ratio

What is CRAD B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CRAD B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	16.4x
Fair PE Ratio	27.5x

Price-To-Earnings vs Fair Ratio: CRAD B is good value based on its Price-To-Earnings Ratio (16.4x) compared to the estimated Fair Price-To-Earnings Ratio (27.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Arcoma

SEK 146.4m

Develops, produces, and provides radiology solutions worldwide.

ARCOMA

SEK 11.10

5.7%

53.1%

Dignitana

SEK 95.8m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.19

8.2%

-44.7%

Iconovo

SEK 80.5m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.06

-0.8%

-45.4%